Who Paid My Doc
Christopher Larson
Interventional Cardiology Lawrence, KS Doctor of Osteopathy
NPI 1467773952 CMS profile 718751
1130 W 4Th St Ste 2050, Lawrence, KS 66044
General payments
$4,333
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$10,480
Through program year 2025, Christopher Larson of Lawrence, KS is reported in the CMS Open Payments database as having received $4,333 across 98 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,480 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 35th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $407 | 11 | |
| 2024 | General | $20 | 1 | |
| 2023 | General | $486 | 8 | |
| 2022 | General | $42 | 2 | |
| 2021 | General | $499 | 16 | |
| 2020 | General | $1,354 | 36 | |
| 2019 | General | $1,526 | 24 |
Beside peers
- Christopher Larson
- Interventional Cardiology median
- Middle half of Interventional Cardiology
- National median
In program year 2025, general payments to Christopher Larson were reported at $407. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.
Show as a table
| Year | Christopher Larson | Interventional Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,526 | $1,097 | $329–$3,048 | $163 |
| 2020 | $1,354 | $473 | $161–$1,480 | $114 |
| 2021 | $499 | $677 | $233–$1,827 | $132 |
| 2022 | $42 | $978 | $333–$2,724 | $149 |
| 2023 | $486 | $1,136 | $382–$2,986 | $160 |
| 2024 | $20 | $1,181 | $395–$3,326 | $164 |
| 2025 | $407 | $1,092 | $366–$3,019 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 58 billing codesPaid by Medicare
$46,202
Medicare patients
456
Services billed
749
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 53% | |
| Arthritis | 51% | |
| Heart failure | 44% | |
| Atrial fibrillation | 43% | |
| Chronic kidney disease | 37% | |
| Diabetes | 36% | |
| Depression | 27% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
98 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Cardiology in Kansas
Anthony Spaedy
Interventional Cardiology · Kansas City, KS
Prasad Gunasekaran
Interventional Cardiology · Kansas City, KS
Maheedhar Gedela
Interventional Cardiology · Wichita, KS
Kamal Gupta
Interventional Cardiology · Kansas City, KS
Priyantha Ranaweera
Interventional Cardiology · Manhattan, KS
Mark Wiley
Interventional Cardiology · Kansas City, KS
Related records
Interventional Cardiology in Kansas
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Kansas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.